VERRICA PHARMACEUTICALS INC (VRCA)
US92511W1080 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12M | 9.03M -24.75% | 5.124M -43.26% | 7.899M 54.16% | 15.781M 99.78% | 38.627M 144.77% | 65.954M 70.75% | 103.06M 56.26% | 135.52M 31.50% | 198.56M 46.52% | 160.85M -18.99% | |
| EBITDA YoY % growth | -30.67M 23.59% | -20.84M 32.05% | -62.672M -200.73% | -59.976M 4.30% | -42.33M 29.42% | -13.362M 68.43% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -30.91M 23.07% | -21.29M 31.12% | -63.222M -196.96% | -71.07M -12.41% | -35.221M 50.44% | -20.844M 40.82% | -11.768M 43.54% | 2.837M 124.11% | 10.697M 277.05% | 46.513M 334.82% | 43.472M -6.54% | |
| Operating Margin | -257.58% | -235.77% | -1,233.84% | -899.73% | -223.19% | -53.96% | -17.84% | 2.75% | 7.89% | 23.43% | 27.03% | |
| EPS YoY % growth | -1.29 24.56% | -0.79 38.76% | -1.46 -84.81% | -1.63 -11.31% | -0.60 63.18% | -0.38 36.36% | 0.14 136.62% | 0.49 248.72% | 0.81 65.72% | 1.24 53.80% | 0.87 -30.04% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 38.42% | -0.10 76.82% | -0.08 77.95% | -0.06 87.51% | -0.06 81.25% |
| Revenue Q2Q % growth | 543.405K -72.67% | 2.151M -43.78% | 4.398M -15.05% | 6.257M 451.32% | 8.169M 1,403.30% |
| EBITDA Q2Q % growth | -13.5M 32.67% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -15.474M 24.88% | -8.289M 55.44% | -8.115M 46.63% | -7.723M 62.70% | -7.132M 53.91% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.49 9.26% | -0.37 | -0.12 | -30.90% |
| Q2 2024 Q2Q % growth | -0.37 -54.17% | -0.43 | 0.06 | 14.57% |
| Q1 2024 Q2Q % growth | -0.44 -193.33% | -0.40 | -0.04 | -8.73% |
| Q4 2023 Q2Q % growth | -0.53 -278.57% | -0.54 | 0.01 | 1.59% |
| Q3 2023 Q2Q % growth | -0.54 -1,900.00% | -0.37 | -0.17 | -46.58% |
| Q2 2023 Q2Q % growth | -0.24 35.14% | -0.21 | -0.03 | -11.94% |
| Q1 2023 Q2Q % growth | -0.15 51.61% | -0.19 | 0.04 | 22.60% |
| Q4 2022 Q2Q % growth | -0.14 60.00% | -0.20 | 0.06 | 28.70% |
| Q3 2022 Q2Q % growth | 0.03 106.38% | -0.12 | 0.15 | 125.86% |
| Q2 2022 Q2Q % growth | -0.37 13.95% | -0.33 | -0.04 | -13.00% |
| Q1 2022 Q2Q % growth | -0.31 -675.00% | -0.48 | 0.17 | 35.61% |
| Q4 2021 Q2Q % growth | -0.35 32.69% | -0.51 | 0.16 | 31.03% |
| Q3 2021 Q2Q % growth | -0.47 -11.90% | -0.52 | 0.05 | 9.29% |
| Q2 2021 Q2Q % growth | -0.43 -13.16% | -0.42 | -0.01 | -1.83% |
| Q1 2021 Q2Q % growth | -0.04 89.74% | -0.35 | 0.31 | 88.71% |
| Q4 2020 Q2Q % growth | -0.52 -67.74% | -0.43 | -0.09 | -22.18% |
| Q3 2020 Q2Q % growth | -0.42 -75.00% | -0.44 | 0.02 | 4.96% |
| Q2 2020 Q2Q % growth | -0.38 -35.71% | -0.46 | 0.08 | 17.21% |
| Q1 2020 Q2Q % growth | -0.39 -30.00% | -0.39 | 0.00 | -0.62% |
| Q4 2019 Q2Q % growth | -0.31 | -0.30 | -0.01 | -3.02% |
| Q3 2019 Q2Q % growth | -0.24 | -0.28 | 0.04 | 12.85% |
| Q2 2019 Q2Q % growth | -0.28 | -0.31 | 0.03 | 8.50% |
| Q1 2019 Q2Q % growth | -0.30 | -0.29 | -0.01 | -3.20% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.781M -161.06% | 4.72M | -6.501M | -137.73% |
| Q2 2024 Q2Q % growth | 5.177M 2,744.51% | 4.454M | 723K | 16.23% |
| Q1 2024 Q2Q % growth | 3.826M 10,240.54% | 2.833M | 993K | 35.05% |
| Q4 2023 Q2Q % growth | 1.988M 2,740.00% | 931.005K | 1.057M | 113.53% |
| Q3 2023 Q2Q % growth | 2.917M -64.94% | 520.965K | 2.396M | 459.92% |
| Q2 2023 Q2Q % growth | 182K -13.33% | 73.44K | 108.56K | 147.82% |
| Q1 2023 Q2Q % growth | 37K -91.40% | 437.917K | -400.917K | -91.55% |
| Q4 2022 Q2Q % growth | 70K | 318.75K | -248.75K | -78.04% |
| Q3 2022 Q2Q % growth | 8.32M | 4.335M | 3.985M | 91.93% |
| Q2 2022 Q2Q % growth | 210K | 318.75K | -108.75K | -34.12% |
| Q1 2022 Q2Q % growth | 430K -96.42% | 265.2K | 164.8K | 62.14% |
| Q2 2021 Q2Q % growth | 255K | -255K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.09% | 0% | -8.78% |
| Revenue | 0% | -94.42% | 0% | -65.2% |